UGT1A1 and Decreased total neutrophil count: Indeed, homozygosity for UGT1A1*28 has been clearly identified as a risk factor for developing severe irinotecan-induced neutropenia, while heterozygous patients seem at intermediate risk (Kim and Innocenti, 2007).